C alifornia-based Meitheal Pharmaceuticals has announced the launch of its liraglutide injections in the US following an approval of US Food and Drug Administration (FDA). This injection is a ...

Learn about side effects, dosage, and more for Victoza (liraglutide), a prescription injection used in adults and some children with type 2 diabetes.

Hikma’s Liraglutide Injection is supplied in an 18mg/3mL prefilled, single-patient-use pen that delivers doses of 0.6mg, 1.2mg, or 1.8mg in packages of 2 and 3 injection pens.

Weight loss injections can help with weight loss. They can help alter the body's appetite and metabolism, ... Saxenda (liraglutide) injection, for subcutaneous use. (2023).

The first-ever generic GLP-1 medication — a duplicate version of Teva Pharmaceuticals' Victoza — was launched on June 25. Doctors explain the potential benefits for diabetes patients.

Meitheal Pharmaceuticals recently launched two new generics. The company released alprostadil injection 500 mcg/ml single-dose vials to the U.S. market, where only an ampoule form is offered.

After a year of treatment, children who received daily liraglutide injections had a 5.8% reduction in body mass index (BMI), while those receiving placebo experienced a 1.6% increase in BMI.

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study.

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...

An old GLP-1 that has since been outshined by Ozempic may have a new path to the limelight. In a small phase 2 trial of patients with mild Alzheimer’s disease, Novo Nordisk’s liraglutide ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. CNN values your feedback 1.